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The growing clinical interest and use of soybean-based food products and extracts to increase dietary phytoestrogen intake 
have led to medical interest in the precise determination of the phytoestrogen composition of soybean products. We have 
analyzed the composition of these compounds in 20 domestic and introduced varieties of genetically non-modified soybean 
genotypes grown under the same agroecological conditions. The isoflavone content of soybeans cultivated in this region of 
Serbia has not been previously reported. The assays were performed, after extraction with methanol-water (8:2, v/v), by        
C18 reversed phase high-performance liquid chromatography coupled with photodiode array detection. The total phytoestrogen 
concentration was found to be between 2.24 and 3.79 mg g-1 dry bean weight. The total concentration of daidzein and its 
derivatives ranged from 0.96 to 1.82 mg g-1, total glyciteines from 0.34-0.53 mg g-1, and all genistein derivatives from        
0.86-1.67 mg g-1 dry bean weight. Given the high biological potency of phytoestrogens and their metabolic conversion 
products, our data suggest that phytoestrogen content screening could be a useful tool in the selection of soybean genotypes 
with improved health promoting characteristics.   
 




Phytoestrogens are plant-derived phenolic 
compounds with estrogenic activity, belonging to the 
class of isoflavones. Soybeans and soy products are 
the richest sources of these compounds in the human 
diet. The health-promoting activity associated with 
soy consumption is partly attributed to the presence 
of phytoestrogens [1]. Soybeans are particularly rich 
sources of phytoestrogens such as daidzein and 
genistein. Intakes of these substances are markedly 
higher among the Asian population than among the 
Western population, largely resulting from soy 
consumption patterns. It is widely perceived that 
exposure to phytoestrogens is beneficial, as the rates 
of breast cancer and other hormone-dependent 
conditions are lower in Asian than in Western 
countries [2]. Recently, soybean constituents with 
biological activity, such as anticarcinogens, 
antioxidants, antihemolytics, antifungal substances, 
and tyrosine protein kinase inhibitors, have attracted 
attention as well [3].  
Soybean phytoestrogens are usually found in 
glycosidic form, such as malonyl and acetyl 
glycosides. It has been shown that malonylated 
isoflavone glycosides are major phytoestrogens in 
soybean seed [4]. Phytoestrogens have similar 
structures to both endogenous and synthetic estrogens 
and show “estrogen like” activities. The anticancer 
function of soybean phytoestrogens was shown to be 
associated with genistein, which inhibits protein 
tyrosine kinase and DNA topoisomerase and binds 
weakly to estrogen receptors [5]. 
 
Twelve different phytoestrogens have been detected 
in soybeans. Daidzein, genistein and glycitein are   
the aglycons, which exist usually as a β-glucoside,    
a 6’’-O-malonyl-glucoside and a 6’’-O-acetyl-
glycoside [6]. Literature evidence suggests that      
the biological activity of soy phytoestrogens does  
not depend upon the glycoside form. For their 
absorption and activity in the organism, hydrolysis  
of the glycosides is necessary [7,8]. Thus, the 
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bioavailability of the soy phytoestrogens is not 
significantly different when they are consumed as 
either aglycone or glucoside [9]. However, the 
activity of the phytoestrogens depends on the type   
of aglycon, as genistein has a higher biological 
activity than daidzein and glycitein [10]. The content 
of phytoestrogens in soybean was found to be about 
0.1-0.4% of dry weight, but the amount and 
composition varied. Wang and Murphy reported total 
phytoestrogen contents from 1176 to 3309 µg/g 
across several years, and from 1176 to 1749 µg/g 
from sites within the same year for single soybean 
cultivars [11].  
 
Medical interest in soy-based food is driven by a 
growing number of studies indicating that the 
phytoestrogen content of ingested soybeans can 
modify the pathogenesis of some hormone-dependent 
and hormone-independent diseases [12-14]. The 
phytoestrogen content of soybean is thus of 
international interest because of the increasing global 
reliance on soybean varieties for animal and human 
consumption, and also because of the newly 
recognized physiological and pharmacological 
properties of phytoestrogens [5,15]. Thus, many 
over-the-counter products of soy isoflavones are 
available in pharmacies as remedies for hot flushes 
and post-menopause related problems [16]. 
 
Due to the widespread use of soy products, knowing 
the amount and kind of phytoestrogens in them is of 
increasing importance. Many of these products are 
derived from phytoestrogen-rich soy sources, yet 
their potency is unknown. Dietetic supplements based 
on soybean extracts have been adopted as a natural 
alternative to hormone replacement therapy in 
menopause due to high amounts of isoflavones [17].  
 
Therefore, the aim of this study was to investigate the 
concentration of phytoestrogens in different soybean 
genotypes grown under defined agroecological 
conditions, not previously studied. Obtained data 
should enable the selection of soybean genotypes 
highly rich in biologically active compounds that 
could further be processed into either functional food 
or pharmaceutical raw material. 
 
The phytoestrogen distribution of twenty soybean 
samples was studied. All twelve described 
isoflavones were successfully separated and 
identified using the applied HPLC conditions. The 
variance of results was lower than 5% for isoflavones 
in each soybean cultivar (n=4).  The highest total  
Table 1: Total daidzein, glycitein, genistein and isoflavone contents of 














Abbreviations: No-sample number; TDZ-total daidzein content; TGLY-
total glycitein content; TGE-total genistein content. 
 
phytoestrogen content was obtained for soybean 
genotype 2 (3.79 mg/g of dried seeds), while the 
lowest was in genotype 3 (2.24 mg/g of dried seeds) 
(Table 1). These results showed that the isoflavone 
content of the analyzed samples is higher than in the 
recently performed study on 30 soybean samples 
from the USA [7]. In that investigation, the total 
isoflavone content ranged between 1.18-2.86 mg/g of 
dried seeds. Also, the average total isoflavone value 
(2.98 mg/g) of all twenty soybean samples analyzed 
in our study is considerably higher than some values 
reported earlier, such as for 30 cultivars from 
Minnesota (1.86 mg/g), 210 South Dakota cultivars 
(average value 1.98 mg/g) [18] and 18 Korean 
(average value 1.45 mg/g) (based on dry weight) 
[11]. 
 
Data analysis by the ANOVA test shows statistically 
significant (p<0.05) differences between the analyzed 
cultivars considering the total isoflavone content, as 
well as for the total amount of genistein, glycitein 
and daizdein. Figure 1 (obtained using the SPSS 10.0 
program) shows the isoflavone contents of the 
analyzed cultivars with regard to three parameters: 
total isoflavone content (x-axis), total genistein 
content (y-axis) and total daidzein content (z-axis).  
No. Cultivar TDZ TGLY TGE TI  
1 LN92-7369 1.41 0.41 1.35 3.17 
2 1581/99 1.66 0.46 1.67 3.79 
3 1511 1.00 0.38 0.86 2.24 
4 1499/99 0.96 0.51 0.93 2.40 
5 lori 0.98 0.53 0.86 2.38 
6 linda 1.54 0.50 1.13 3.16 
7 balkan 1.82 0.49 1.21 3.52 
8 BL-8 1.56 0.50 1.54 3.60 
9 alisa 1.03 0.34 1.11 2.48 
10 tara 1.05 0.50 0.96 2.52 
11 meli 1.60 0.53 1.49 3.62 
12 sava 1.50 0.42 1.11 3.03 
13 venera 1.61 0.42 1.37 3.40 
14 morava 1.60 0.43 1.17 3.20 
15 LN92-7369 
x 1581/99 1.41 0.44 1.26 3.11 
16 1499/99 x 
1581/99 1.28 0.48 1.18 2.94 
17 1499/99 x 
1511 1.07 0.37 1.08 2.51 
18 lori x 
LN92-7369 1.06 0.38 0.93 2.38 
19 linda x 
LN92-7369 1.55 0.43 1.31 3.29 
20 balkan x 
BL-8 1.27 0.34 1.14 2.74 
average  1.35 0.44 1.18 2.98 
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Figure 2: Distribution of isoflavone content in analyzed cultivars, 
regarding total isoflavones, total genisteins and total daidzeins. 
 
Two main distinctive groups of cultivars could be 
recognized; these are marked in red and yellow. From 
all analyzed cultivars, samples with the highest 
content of total isoflavones have been placed in the 
yellow graph area. It can be noticed that samples 2, 8 
and 11, placed in the orange subgroup, are 
distinguished from the other samples by containing 
also the highest amount of genisteins. This might be 
important considering that daidzein and glycitein 
forms have less estrogenic activity than genistein 
forms [7].  
 
The cultivars with the lowest total isoflavone content 
are in the red area of the diagram. At the same time, 
all the samples in that area have the lowest total 
genistein content. Therefore, by looking at the graph, 
we can clearly distinguish soybeans with different 
potential for biological activity, and thus the best 
cultivars for development for pharmaceutical and/or 
food supplements. The best isoflavone composition 
was found in cultivars no 2, 11 and 8, taking into 
consideration the content of total isoflavones (1.63; 
1.51; 1.46 mg/g, respectively) and the contribution of 
total genisteins in the total isoflavone content of 44, 
41 and 43%, respectively.  
 
The isoflavone contents of 20 analyzed soybean 
cultivars are shown in Table 2. The two last rows in 
the table represent the minimal and maximal standard 
deviation for the 4 different analyses of the same 
sample. Considering the average contents of all 
analyzed samples, the most abundant components 
were malonyl daidzin (1.53 mg/g, dry weight) and 
malonyl genistin (1.53 mg/g, dry weight), while the 
concentration of acetyl genistin was the lowest (0.01 
mg/g, dry weight). This observation is in agreement 
with previously reported results [1,11,19,20,]. 
Daidzin and genistin are present in considerable 
amounts in all soybean samples (average values are 
0.70 and 0.56 mg/g, dry weight, respectively). 
 
In the analyzed soybeans, isoflavones were mostly 
present in the form of glycosides. The average 
content of isoflavones in the free aglycon forms 
(daidzein, glycitein and genistein) is only 0.92% of 
the total isoflavone content. Isoflavones are 
dominantly present as malonyl glucosides. On 
average, regarding all the twenty analyzed samples, 
malonyl glucosides (malonyl daidzin, malonyl 
glycitin and malonyl genistin) represented 67% of the 
total isoflavone content. The average sum of 
glucoside derivatives (daidzin, glycitin and genistin) 
formed 27% of total isoflavones, and the 
acetylglucosides (acetyl daidzin, acetyl glycitin and 
acetyl genistin) existed only in small proportions; 
these data are consistent with the literature reports 
[3,11,19]. 
 
In Figure 2, the distribution of total daidzeins, total 
glyciteins and total genisteins is shown, in relation to 
the total isoflavone content. Daidzeins varied 
between 41-52% of the total, genisteins from 34-
45%, and glyciteins from 12-22%. The average 
amount of total daidzeins in the analyzed cultivars 
was the highest (45.6%), followed by total genisteins 
(39.3%), while total glyciteins were present in the 
least amount in all analyzed samples (15.0%). The 
ratios of total daidzin, total glycitin and total genistin 
contents compared with total isoflavone content are 
similar in all 20 analyzed cultivars. These results are 
in agreement with the previous observations that 
soybeans and soy food usually contain similar 
amounts of genistein and daidzein forms and a much 
lower amount of glycitein forms [11, 20].The results 
related to the antioxidant activity of the same samples 
used in this study are previously reported [21]. By 
comparison of these results with those obtained from 
our analysis we can conclude that there was no 
correlation between the content of total isoflavones 
and antioxidant activity in analyzed soybean seeds 
(p>0.05). Soy isoflavones seemed to be less effective 
antioxidants compared with other compounds present 
in soybean [22]. This may be due to dependence of 
antioxidant activitiy on isoflavone structure. For 
example, the glucose linkage to the aglycone reduced 
the antioxidant activities of isoflavones by 
approximately 50-100 times [23]. 
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Table 2: Isoflavone content of analyzed cultivars (mg/g dry plant material). 
 
Sample DE DI mDI aDI GY GYI mGYI aGYI GE GI mGI aGI 
1 0.02 0.58 1.76 0.27 0.03 0.15 0.47 0.07 0.07 0.47 1.82 0.01 
2 0.02 0.69 2.00 0.37 0.04 0.15 0.54 0.09 0.02 0.66 2.32 tr 
3 0.02 0.45 1.16 0.21 0.03 0.13 0.42 0.07 0.01 0.35 1.18 tr 
4 tr 0.42 1.13 0.24 0.03 0.20 0.62 0.07 0.01 0.36 1.29 tr 
5 tr 0.45 1.17 0.21 0.02 0.29 0.57 0.06 0.01 0.35 1.18 tr 
6 tr 0.71 1.91 0.25 0.03 0.19 0.59 0.07 0.00 0.48 1.55 tr 
7 0.02 0.88 2.20 0.27 0.02 0.15 0.61 0.09 0.01 0.53 1.62 tr 
8 tr 0.77 1.78 0.35 0.03 0.20 0.57 0.09 0.01 0.72 2.02 tr 
9 tr 0.53 1.15 0.23 0.02 0.13 0.38 0.08 0.01 0.50 1.47 tr 
10 tr 0.53 1.21 0.22 0.02 0.23 0.58 0.06 0.00 0.44 1.26 tr 
11 tr 0.82 1.83 0.31 0.03 0.19 0.65 0.07 0.01 0.69 1.96 tr 
12 0.01 0.83 1.68 0.24 0.03 0.15 0.51 0.06 0.01 0.55 1.41 tr 
13 0.03 0.85 1.81 0.28 0.02 0.15 0.50 0.07 0.01 0.71 1.69 tr 
14 0.02 0.87 1.78 0.27 0.03 0.16 0.52 0.06 0.01 0.59 1.47 tr 
15 0.01 0.76 1.55 0.28 0.03 0.21 0.50 0.04 0.01 0.63 1.59 tr 
16 tr 0.71 1.39 0.27 0.02 0.22 0.57 0.04 0.01 0.63 1.44 tr 
17 tr 0.62 1.13 0.22 0.02 0.15 0.42 0.05 0.01 0.61 1.29 tr 
18 tr 0.63 1.14 0.19 0.03 0.21 0.42 0.02 0.01 0.52 1.12 tr 
19 0.01 0.91 1.68 0.26 0.03 0.21 0.47 0.04 0.01 0.71 1.58 tr 
20 0.02 0.80 1.26 0.23 0.02 0.16 0.36 0.05 0.01 0.71 1.32 tr 
Av. 0.02 0.69 1.53 0.26 0.03 0.18 0.51 0.06 0.01 0.57 1.53 0.01 
Min StD x10-5 4.0 0.6 5.5 0.9 0.9 0.1 0.13 2.9 1.5 2.4 0.9 35.2 
Max StD x10-5 83.5 218.5 268.8 65.8 42.0 127.4 310.7 104.6 56.0 105.8 163.1 35.2 
Abbreviations: DE, daidzein; DI, daidzin; mDI, malonyl daidzin, aDI, acetyl daidzin; GY, glycitiein; GYI, glycitin; mGYI malonyl glycitin, aGYI acetyl 
glycitin; GE genistein; GI, genistin; mGI, malonyl genistin; aGI acetyl genistin; TI, total isoflavone; tr, trace amount; av, average value; Min StD, Minimal 




Figure 2: Total daidzein, total glycitein and total genistein distribution in 
20 soybean cultivars 
 
Experiments on antioxidant activity of isoflavone 
aglycones in vivo showed significantly lower 
excretion of urinary secondary lipid oxidation 
products, a measure of lipid peroxidation in vivo [24]. 
The low percentage of isoflavones in aglycone form 
(less than 1% in analyzed samples) may cause the 
relatively low antioxidant activities of soybean 
extracts. The prospective comparison of the 
antioxidant activity before and after hydrolysis of 
glycosides in soybean extracts should reveal more 
detailed information related to their effectiveness.  
 
The actual phytoestrogen concentrations in this crop 
are of interest because of the growing number of 
professionals who may recommend increasing dietary 
intake of phytoestrogens to modulate lipid oxidation 
[25,26], retard the pathogenesis of cancer, notably 
breast cancer [27], and reduce the risks of coronary 
artery disease and osteoporosis [28,29]. There is also 
growing interest in the commercialization of 
phytoestrogen preparations and soy extracts. 
Introduction of selection criteria based on bioactive 
properties could help in developing soybean 
genotypes with better health promoting 
characteristics.   
 
In this study twenty soybean cultivars were analyzed 
for isoflavone contents. The objective was to 
compare results between cultivars and to determine 
selection criteria for developing genotypes with 
favorable health promoting characteristics. Also, 
considering that the investigated soybeans were 
cultivated in a region not generally accepted as their 
ecological surroundings, the results obtained were of 
value for comparison with the isoflavone contents of 
soybeans bred in previously reported regions. The 
total isoflavone values of all twenty soybean samples 
analyzed in our study were considerably higher than 
some reported earlier [11,18]. Our analysis showed 
that, considering isoflavone distribution, some 
specific cultivars can be distinguished. Of the 
investigated samples, there was a group which 
exhibited a significantly higher content of isoflavones 
than the others. The group with the higher content   
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of genisteins, biologically the most active 
phyotoestrogen, could also be clearly distinguished. 
It has been shown that the isoflavone content should 
be considered an important characteristic of soybean 
seeds. Phytoestrogen screening could provide 
valuable information regarding the capacity for 
biological activity of different soybean cultivars and, 
at the same time, could be useful for selection of 
cultivars for pharmaceutical purposes. Our results 
suggest that analyzed genotypes may be of interest to 
producers, plant breeders and phytopharmacists due 




Materials: The seeds of 14 soybean genotypes grown 
on experimental fields at Rimski Šančevi, near Novi 
Sad, were obtained from the Institute of Field and 
Vegetable Crops in Novi Sad, Serbia. Daidzein was 
purchased from Fluka (Buch, Switzerland), genistein 
from Serva (Heidelberg, Germany) and glycitein 
from Aldrich (Steinheim, Germany). Solvents used 
for sample preparation, ethanol and n-hexane, were 
of analytical grade and purchased from Centrohem 
(Šabac, Serbia). Methanol and acetonitrile were of 
HPLC grade and purchased from J.T. Baker 
(Deventher, Netherlands). 
 
Sample preparation: All the samples were harvested 
on the same day and were stored for 2 months in a 
storage room, without removal of the seed coat. The 
moisture content of seeds, determined by heating at 
105ºC to constant weight, was 5.5%. For further 
analysis, soybeans were ground using a coffee mill. 
A powdered portion (500 mg) was defatted by 
extraction with n-hexane (2 x 10 mL for 30 min), 
followed by centrifugation for 30 min at 3500 rpm, 
then extracted for 2 h with 8 mL methanol-water 
(8:2, v/v) and centrifuged (30 min, 3500 rpm) [29]. 
Prior to HPLC injection, each extract was passed 
through a 0.45 µm membrane filter. 
HPLC analysis: An Agilent model 1100 HPLC 
equipped with binar pump, degaser, autosampler and 
diode array detector (DAD) was used to separate, 
identify and quantify phytoestrogens. Separation of 
these compounds was achieved using a 5 µm Zorbax 
SB C18 reversed phase HPLC column (150 x 4.6 mm) 
with a Zorbax SB C18 guard column. Mobile phase 
gradients were formed between two degassed 
solvents. Solvent A was 1% (v/v) acetic acid in water 
and solvent B 100% acetonitrile. Gradient conditions 
were: 0-5 min 15% B; 5-44 min from 15 to 35% B; 
44-45 min from 35 to 15% B, 45-50 min 15% B. A 
post-time period of 20 minutes was applied. The 
column temperature was 25°C, the solvent flow rate 
0.6 mL/min and the injection volume 10 µL. The 
spectra were collected between 240 and 400 nm by 
DAD and components in the eluate were detected at 
260 nm. Phytoestrogens were identified by retention 
times, by comparison of UV spectra with those of 
standard compounds, and from literature data. 
 
Aglycons were quantified from three five-point 
regression curves (R ≥ 0.9998) obtained using the 
corresponding standards (daidzein, glycitein and 
genistein). Actual concentrations of phytoestrogens 
in glycoside forms were calculated from the 
regression curve of the corresponding aglycones, 
after applying corrections for differences in 
molecular weight between aglycones and glycosides. 
 
Statistical analysis: Isoflavone analysis of each 
cultivar was repeated in quadruplicate. The data were 
analyzed statistically using analysis of variance 
(Origin 6.1); p value < 0.05 was considered 
significant. For the data analysis, the SSPS 10.0 
program was also used. 
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